Recombinant Fusion Proteins [CS] - M0018640

Pharmacologic Class Information

Pharmacologic Code M0018640
Pharmacologic Name Recombinant Fusion Proteins
Pharmacologic Uses
  • bispecific CD19-directed CD3 T-cell engager
  • CD25-directed cytotoxin
  • CD2-directed LFA-3/Fc fusion protein
  • selective T cell costimulation modulator
Pharmacologic Concept Chemical Structure - [CS]
Pharmacologic Concept Description This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

NDC Products with Recombinant Fusion Proteins

The following table contains 4 products whose active ingredient are classified under the same pharmacologic class Recombinant Fusion Proteins [CS].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0003-2187Orencia Non-Proprietary Name: AbataceptInjection, Powder, Lyophilized, For SolutionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2188Orencia Non-Proprietary Name: AbataceptInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2814Orencia Non-Proprietary Name: AbataceptInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2818Orencia Non-Proprietary Name: AbataceptInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE